CEACAM20 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-09600
Key Product Details
Species Reactivity
Human
Applications
Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit
Concentration
0.5 mg/ml
Product Specifications
Immunogen
The immunogen is a synthetic peptide directed towards the C-terminal region of Human CEACAM20. Peptide sequence VIAVASELGYFLCIRNARRPSRKTTEDPSHETSQPIPKEEHPTEPSSESL
Clonality
Polyclonal
Host
Rabbit
Theoretical MW
64 kDa.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Scientific Data Images for CEACAM20 Antibody
Western Blot: CEACAM20 Antibody [NBP3-09600]
Western Blot: CEACAM20 Antibody [NBP3-09600] - Western blot analysis of CEACAM20 in THP-1 Whole Cell lysates. Antibody dilution at 1.0ug/mlApplications for CEACAM20 Antibody
Application
Recommended Usage
Western Blot
1.0 ug/ml
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, 2% Sucrose
Preservative
0.09% Sodium Azide
Concentration
0.5 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
Background: CEACAM-20
Long Name
Carcinoembryonic Antigen-related Cell Adhesion Molecule 20
Alternate Names
CEACAM20, GPAD9366, UNQ9366
Gene Symbol
CEACAM20
Additional CEACAM-20 Products
Product Specific Notices for CEACAM20 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...